Nureca Ltd
NSE:NURECA

Watchlist Manager
Nureca Ltd Logo
Nureca Ltd
NSE:NURECA
Watchlist
Price: 282.8 INR -3.38% Market Closed
Market Cap: 2.8B INR
Section:
 

Relative Value

The Relative Value of one NURECA stock under the Base Case scenario is 317.11 INR. Compared to the current market price of 282.8 INR, Nureca Ltd is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NURECA Relative Value
Base Case
317.11 INR
Undervaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.2
P/S
P/S
Price to Sales
2.2
vs History
78
vs Industry
42
Median 3Y
3
Median 5Y
3.2
Industry
2.3
More Details
68.8
P/E
P/E
Price to Earnings
68.8
vs History
24
vs Industry
1
Median 3Y
-43.5
Median 5Y
15.7
Industry
22.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
10
Median 3Y
-27.8
Median 5Y
-30.8
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
8
Median 3Y
-11.4
Median 5Y
-24.7
Industry
21.4
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
60
vs Industry
58
Median 3Y
1.5
Median 5Y
1.8
Industry
2.2
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
70
vs Industry
68
Median 3Y
1.6
Median 5Y
2
Industry
2.5
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
73
vs Industry
61
Median 3Y
4.6
Median 5Y
5.7
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-16.8
Median 5Y
-13.7
Industry
11.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-14
Median 5Y
-11.4
Industry
16.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
30
Median 3Y
-15.2
Median 5Y
-19.1
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
21
Median 3Y
-5.3
Median 5Y
-16.8
Industry
18.6
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
78
vs Industry
49
Median 3Y
2.5
Median 5Y
3.2
Industry
1.9
More Details

Multiples Across Competitors

NURECA Competitors Multiples
Nureca Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Nureca Ltd
NSE:NURECA
2.8B INR 2.2 68.8 -1 086.9 -70.6
US
Abbott Laboratories
NYSE:ABT
218.6B USD 5 15.7 19.9 27.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
210.6B USD 21.8 76.4 58.8 71.8
US
Boston Scientific Corp
NYSE:BSX
145.1B USD 7.5 52.1 30.3 41.3
US
Stryker Corp
NYSE:SYK
140.9B USD 5.8 48 23.3 28.2
IE
Medtronic PLC
NYSE:MDT
124.8B USD 3.6 26.3 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
52.6B EUR 2.2 24.5 13.8 19.4
US
Becton Dickinson and Co
NYSE:BDX
58B USD 2.6 34.7 12.7 21.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD 13.7 55.6 39.9 44.2
US
Edwards Lifesciences Corp
NYSE:EW
49.5B USD 8.4 36.3 25.9 28.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.8B USD 1.9 17.8 13.3 16.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Nureca Ltd
NSE:NURECA
Average EV/EBITDA: 25.3
Negative Multiple: -1 086.9 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.9
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.8
26%
2.3
US
Boston Scientific Corp
NYSE:BSX
30.3
22%
1.4
US
Stryker Corp
NYSE:SYK
23.3
13%
1.8
IE
Medtronic PLC
NYSE:MDT
14.8
8%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
13.8
11%
1.3
US
Becton Dickinson and Co
NYSE:BDX
12.7
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.9
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.9
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13.3
10%
1.3

See Also

Summary
NURECA intrinsic value, competitors valuation, and company profile.
DCF Valuation
NURECA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NURECA stock valuation using valuation multiples.
Wall Street Estimates
NURECA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NURECA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.